Compare AXR & CLPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AXR | CLPT |
|---|---|---|
| Founded | 1961 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Homebuilding | Medical/Dental Instruments |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 110.8M | 494.6M |
| IPO Year | 2010 | 2009 |
| Metric | AXR | CLPT |
|---|---|---|
| Price | $28.78 | $11.24 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $21.50 |
| AVG Volume (30 Days) | 7.6K | ★ 882.6K |
| Earning Date | 06-23-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 89.60 | 22.22 |
| EPS | ★ 1.68 | N/A |
| Revenue | $12,831,000.00 | ★ $31,390,000.00 |
| Revenue This Year | $12.43 | $18.93 |
| Revenue Next Year | $4.48 | $51.64 |
| P/E Ratio | $17.22 | ★ N/A |
| Revenue Growth | N/A | ★ 31.04 |
| 52 Week Low | $17.60 | $8.63 |
| 52 Week High | $29.00 | $30.10 |
| Indicator | AXR | CLPT |
|---|---|---|
| Relative Strength Index (RSI) | 69.19 | 45.32 |
| Support Level | $20.58 | $10.57 |
| Resistance Level | N/A | $11.69 |
| Average True Range (ATR) | 1.09 | 0.96 |
| MACD | 0.12 | 0.06 |
| Stochastic Oscillator | 90.80 | 42.23 |
Amrep Corp through its subsidiaries is engaged in the Real estate business. Its activities include land sales and lease activities, which involve obtaining approvals and selling both developed and undeveloped lots to homebuilders, commercial users, and others, as well as investments in commercial and investment properties. The Company accounts for land sales, home sales, and other revenues. Its operating segments include Land development and Homebuilding. The firm generates a majority of its revenue from the Land development segment. Geographically, all the activities are carried out throughout the United States.
ClearPoint Neuro Inc is a medical device company based in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain and heart under direct, intra-procedural magnetic resonance imaging (MRI) guidance. The company's ClearPoint system, which is in commercial use, is used to perform minimally invasive surgical procedures in the brain. The company's products include the ClearPoint system, ClearPoint Services, ClearPoint Disposables, ClearPoint Software, and ClearPoint Therapeutic Solutions.